Cor Vasa 2013, 55(6):e520-e524 | DOI: 10.1016/j.crvasa.2013.05.006

What's new in the prevention of infective endocarditis?

Pavel Gregor
III. interní-kardiologická klinika, Kardiocentrum, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha, Česká republika

The concept of prophylaxis of infective endocarditis has changed substantially in recent years; currently, prophylaxis is recommended only in patients at highest risk of developing infective endocarditis who are scheduled for dental procedures involving the gingiva. The risk is also increased in individuals with pacemakers and implantable cardioverter-defibrillators. Other high-risk populations include polymorbid patients (diabetes mellitus or chronic hemodialysis), the elderly (particularly those aged 75-79 years), and males. In indicated cases, the drugs used in prevention include amoxycillin or ampicillin.

Keywords: Infective endocarditis; Prevention of infective endocarditis; Prophylaxis prior to dental procedures; Staphylococcal endocarditis

Received: February 28, 2013; Revised: May 16, 2013; Accepted: May 20, 2013; Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregor P. What's new in the prevention of infective endocarditis? Cor Vasa. 2013;55(6):e520-524. doi: 10.1016/j.crvasa.2013.05.006.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. C. Chirouze, B. Hoen, X. Duval, Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention?, European Journal of Clinical Microbiology & Infectious Diseases 31 (2012) 2089-2095. Go to original source... Go to PubMed...
    2. A. Wang, The changing epidemiology of infective endocarditis. The paradox of prophylaxis in the current and future eras, Journal of the American College of Cardiology 59 (2012) 1977-1978. Go to original source... Go to PubMed...
    3. J. Beneš, R. Baloun, O. Džupová, Endokarditidy 2007. Výsledky multicentrické studie o výskytu a vlastnostech infekční endokarditidy, Vnitřní lékařství 57 (2011) 147-154. Go to PubMed...
    4. P. Gregor, Výskyt infekční endokarditidy a některé problémy její diagnostiky, Vnitřní lékařství 57 (2011) 130-131. Go to PubMed...
    5. C. Selton-Suty, M. Celard, V. Moing, et al., Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey, Clinical Infectious Diseases 54 (2012) 1230-1239. Go to original source... Go to PubMed...
    6. American Heart Association, Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections, Circulation 11 (1955) 317-320.
    7. J. Beneš, P. Gregor, Infekční endokarditida, Triton, Praha, 2002, p. 182.
    8. J. Beneš, P. Gregor, A. Mokráček, Infekční endokarditida: doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe, Cor et Vasa 49 (2007) K157-K171.
    9. G. Habib, B. Hoen, P. Tornos, et al., Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009), European Heart Journal 30 (2009) 2369-2413. Go to original source... Go to PubMed...
    10. W. Wilson, K.A. Taubert, M. Gewitz, et al., Prevention of infective endocarditis: guidelines from the American Heart Association: Rheumatic fever, endocarditis, and Kawasaki disease Committee, Circulation 116 (2007) 1736-1754. Go to original source... Go to PubMed...
    11. R.A. Nishimura, B.A. Carabello, D.P. Faxon, et al., ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation 118 (2008) 887-896. Go to original source... Go to PubMed...
    12. National Institute for Health and Clinical Excellence (NICE), Prophylaxis against infective endocarditis (CG64). Antimicrobial prophylaxis against infective endocarditis, London, NICE, http://www.nice.org.uk/CG064
    13. J.T. Van Der Meer, W. Van Wijk, J. Thomson, et al., Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis, Lancet 339 (1992) 135-139. Go to original source...
    14. B.L. Strom, E. Abrutyn, J.A. Berlin, et al., Risk factors for infective endocarditis: oral hygiene and nondental exposures, Circulation 102 (2000) 2842-2848. Go to original source... Go to PubMed...
    15. F. Lacassin, B. Hoen, C. Leport, et al., Procedures associated with infective endocarditis in adults. A case control study, European Heart Journal 16 (1995) 1968-1974. Go to original source...
    16. P.B. Lockhart, The risk for endocarditis in dental practice, Periodontology 23 (2000) 127-135. Go to original source...
    17. J.M. Steckelberg, W.R. Wilson, Risk factors for infective endocarditis, Infectious Disease Clinics of North America 7 (1993) 9-19. Go to original source... Go to PubMed...
    18. T.J. Pallasch, Antibiotic prophylaxis: problems in paradise, Dental Clinics of North America 47 (2003) 665-679. Go to original source... Go to PubMed...
    19. A. Parrish, B. Maharaj, Prevention of infective endocarditis in developing countries - justifiable caution?, South African Medical Journal 102 (2012) 652-654. Go to original source... Go to PubMed...
    20. G.J. Roberts, Dentists are innocent! "Everyday" bacteriemia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children, Pediatric Cardiology 20 (1999) 317-325. Go to original source... Go to PubMed...
    21. X. Duval, C. Leport, Prophylaxis of infective endocarditis: current tendencies, continuing controversies, Lancet Infectious Diseases 8 (2008) 225-232. Go to original source... Go to PubMed...
    22. H. Allen, Infective endocarditis: Updated guidelines, Canadian Journal of Infectious Diseases & Medical Microbiology 21 (2010) 205-212. Go to original source...
    23. X. Duval, F. Alla, B. Hoen, et al., Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis, Clinical Infectious Diseases 42 (2006) e102-e107. Go to original source... Go to PubMed...
    24. E. Athan, V.H. Chu, P. Tattevin, et al., Clinical characteristics and outcome of infective endocarditis involving implantable cardiac device, Journal of the American Medical Association 307 (2012) 1727-1735. Go to original source... Go to PubMed...
    25. J.C. de Oliveira, M. Martinelli, S.A. Nishioka, et al., Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial, Circulation: Arrhythmia and Electrophysiology 2 (2009) 29-34. Go to original source... Go to PubMed...
    26. L.M. Baddour, A.E. Epstein, C.C. Ericsson, et al., Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association, Circulation 121 (2010) 458-477. Go to original source... Go to PubMed...
    27. D.R. Mudroch, G.R. Corey, B. Hoen, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study, Archives of Internal Medicine 169 (2009) 463-473. Go to original source...
    28. N. Benito, J.M. Miro, E. de Lazzari, et al., Health care-associated native valve endocarditis: importace of non-nosocomial acquisition, Annals of Internal Medicine 150 (2009) 586-594. Go to original source...
    29. C.H. Cabell, J.G. Jollis, G.E. Peterson, et al., Changing patient chacteristics and the effect on mortality in endocarditis, Archives of Internal Medicine 162 (2002) 633-638. Go to original source... Go to PubMed...
    30. J.S. Li, D.J. Sexton, N. Mick, et al., Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clinical Infectious Diseases 30 (2000) 633-638. Go to original source... Go to PubMed...
    31. F. Thuny, R. Giorgi, R. Habachi, et al., Excess mortality and morbidity in patients surviving infective endocarditis, American Heart Journal 164 (2012) 94-101. Go to original source... Go to PubMed...
    32. V.H. Chu, J.M. Miro, B. Hoen, et al., Coagulase-negative staphylococcal prosthetic valve endocarditis - a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study, Heart 95 (2009) 570-576. Go to original source...
    33. M, Sabe N. Shrestha, S. Gordon, et al., Staphylococcus lugdunensis: a rare but destructive cause of infective endocarditis with echocardiographic and clinical features similar to Staphylococcus aureus infective endocarditis, Journal of the American College of Cardiology 59(2012)248
    34. M. Ahmed, D. Sanghavi, A bug that bites a normal heart: case report and review of infective endocarditis by Staphylococcus lugdunensis, Journal of the American College of Cardiology 59 (2012) 245. Go to original source...
    35. M. Yoshinaga, K. Niwa, A. Niwa, et al., Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease, The American Journal of Cardiology 101 (2008) 114-118. Go to original source... Go to PubMed...
    36. M.H. Thornhill, M.J. Dayer, J.M. Forde, et al., Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study, British Medical Journal 342 (2001) 2392. Go to original source...
    37. X. Duval, F. Delahaye, F. Alla, et al., Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications. Three successive population-based surveys, Journal of the American College of Cardiology 59 (2012) 1968-1976. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes